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Abstract 
Affective instability, conceptualized as fluctuations in mood over time, has been related to ill-health and 
psychopathology. In this study we examined the role of affective instability upon daily pain outcomes in 
70 chronic pain patients (Mage = 49.7 years; 46 females) using an end-of-day diary. During a baseline 
phase, patients completed self-reported questionnaires of pain severity, pain duration, disability, 
depression and anxiety. During a subsequent diary phase, patients filled out an electronic end-of-day diary 
over 14 consecutive days assessing daily levels of pain severity, disability, cognitive complaints, negative 
affect (NA) and positive affect (PA). Affective instability was operationalized as the mean square of 
successive differences (MSSD) in daily mood (separately for NA and PA), which takes into account the 
size of affective changes over consecutive days. Results indicated that NA instability was positively 
associated with daily disability, beyond the effects of daily pain severity. Furthermore, NA instability 
moderated the relationship between daily pain severity and daily disability and the relationship between 
daily pain severity and daily cognitive complaints. PA instability, however showed to be unrelated to all 
outcomes. Current findings extend previous results and reveal the putative role of affective instability 
upon pain-related outcomes and may yield important clinical implications. Indeed, they suggest that 
targeting NA instability by improving emotion regulation skills may be a strategy to diminish disability 
and cognitive complaints in patients with chronic pain.  
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1. Introduction 
Emotions change following the ebb-and-flow of daily life. However, experiencing unusually large 
and/or frequent changes in emotion, labeled affective instability, can be considered dysfunctional [55,56]. 
Affective instability may reflect problems in regulating affect [8,47], which is a key feature of mental 
disorders [20]. In line with this view, affective instability has been found to be associated with lower well-
being and various forms of psychopathology [15,25,55,56]. To our knowledge, there are no studies that 
have investigated the role of affective instability in patients with chronic pain.  
There is abundant research demonstrating that patients with chronic pain report high levels of 
negative affect (NA) and low levels of positive affect (PA) on self-report questionnaires [1,41,62]. 
Questionnaire research, however, does not capture well the temporal dynamics of affect. Indeed, chronic 
pain patients experience fluctuations not only in pain [49], but also in NA and PA [52,63,64]. 
Investigating moment-to-moment variations in affect may further our understanding of chronic pain and 
associated problems. As an example, Sturgeon and colleagues (2014) showed that the relationships 
between daily PA and pain as well as daily NA and pain were mediated by positive interpersonal events 
and pain catastrophizing [53]. Similarly, Connelly and colleagues (2007) found that changes in PA and 
NA from the prior day to the current day predicts significantly greater decreases in pain that day [12]. In 
the current study, we examined the potential role of affective instability, an index that captures both the 
frequency and size of affective fluctuations [26], upon pain and its outcomes. This is in line with previous 
research which suggests that affect regulation may be a key factor for the adjustment to pain [22]. 
Affective instability may be considered an indicator of dysregulated affect [8,47]. As pain is 
conceptualized as a sensory and emotional experience, affective instability is likely to be closely related to 
the dysfunctional regulation of pain. With increasing affective instability, we may expect pain to interfere 
more with daily activities and cognitive processes [2,17,57]. Based on the results of a recent meta-analysis 
on the role of affective instability in psychological well-being [25], we expected NA instability to have a 
stronger influence on daily pain outcomes. 
To investigate the role of affective instability, the current study assessed day-to-day fluctuations in 
levels of pain and mood using end-of-day diaries over 14 consecutive days. This method allowed us to 
investigate the impact of the dynamics of PA and NA on daily pain outcomes, i.e. disability and cognitive 
complaints. In particular, we were interested (1) to what extent NA and PA instability were related to 
standard measures of emotional functioning, such as anxiety and depression, (2) whether NA and PA 
instability were related to daily pain outcomes (disability and cognitive complaints), and (3) whether NA 
and PA instability moderated the relationship between daily pain severity on the one hand and daily 
disability and cognitive complaints on the other hand. 
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2. Method 
2.1. Participants 
This study reports secondary analyses of data from the Ghent Pain Disability – I (GPD-I) Study. 
Previous research has been reported using a part of these data, but had other research objectives [see 59]. 
Detailed information on recruitment, primary research objectives and variables assessed can be found on 
the website (http://hdl.handle.net/1854/LU-3050986). We briefly report the most relevant information. 
518 members of the Flemish Pain League responded to an invitation letter of which 315 agreed to be 
contacted by phone. 276 persons were actually contacted by phone. Patients were recruited in February 
and March 2011. Inclusion criteria were: 1) age between 18 and 65 years; 2) sufficient knowledge of the 
Dutch language; and 3) pain that lasted for at least six months. Individuals were excluded if headache pain 
was the most important pain [cfr. 36] (n = 1), when they were unable to use both index fingers (n = 1) or 
when their eyesight was not normal or corrected-to-normal (e.g. by glasses) (n = 2). The latter two 
exclusion criteria were used as participants had to be able to perform a computer task. However, this task 
was not part of this study. 81 patients fulfilled the inclusion criteria and agreed to participate. The need to 
travel to the university campus to participate in this study was mentioned as the most frequent reason for 
nonparticipation. Seven more patients did not participate because of health problems. The final sample of 
patients consisted of 74 individuals with chronic pain.  
Patients filled out some standard questionnaires (STAI-T, HADS-D, PDI, MPI) via an online 
assessment system at home. When arriving at the research lab, patients filled out the STAI-S. All these 
measures are labeled as “baseline” measures. Next, they participated in an experiment (see also 59) and 
received instructions for the diary study. The diary study started one day after the visit to the research lab. 
Patients filled out an online end-of-day diary for 14 consecutive days. Measures from the diary are labeled 
“daily” measures. The study design was approved by the Ethics Committee of the Faculty of Psychology 
and Educational Sciences of Ghent University. Patients provided written informed consent and received a 
monetary compensation for their participation. 
2.2. Questionnaires 
State and trait anxiety were measured with the State-Trait Anxiety Inventory (STAI) [51,58]. This 
questionnaire consists of 40 items asking people to report how they feel in general (e.g. I feel nervous) and 
at present (e.g. I feel at ease) using a scale from 1 (almost never/not at all) to 4 (almost always/very much 
so). Scores for the trait and state version may vary between 20 and 80. This questionnaire shows good 
reliability and validity [5,50]. In the present study Cronbach’s alpha was .93 for the trait version and .93 
for the state version.  
Depressive mood was assessed by means of the depression subscale of Hospital Anxiety and 
Depression Scale (HADS-D) [65]. The HADS-D is designed to screen for depression during the last week 
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and has been developed for patients with “medical conditions”. It consists of seven items rated on a 4-
point Likert scale. Scores may range from 0 to 21. In the present study, Cronbach’s alpha of the HADS-D 
was .81.  
Disability because of pain was measured with the Pain Disability Index (PDI) [40]. Patients 
indicate the degree of disability experienced in seven life domains (e.g. family and occupation) using a 
scale from 0 (no disability) to 10 (total disability). They are asked to respond to each category by 
indicating the overall impact of pain in their life, not just when pain is at its worst. Scores may vary 
between 0 and 70. In the present study, Cronbach’s alpha of the PDI was .81.  
Pain severity was assessed with the pain severity subscale of the Multidimensional Pain Inventory 
(MPI) [27,31]. Part I of the MPI consists of 5 subscales assessing the impact of pain (i.e. pain severity, 
pain interference, social support, perceived life control and affective distress) on a 7-point Likert scale. 
Pain severity was assessed by means of two items (i.e., “Rate the level of your pain at the present 
moment” and “On average, how severe has your pain been during the last week?”). The third item (“How 
much suffering do you experience because of your pain?”) was not taken into account as its content relates 
to suffering rather than pain severity [see 39]. The MPI showed a good reliability and validity [45]. In the 
present study, Cronbach’s alpha of the MPI severity subscale was .82.  
 
2.3. End-of-day diary assessment 
Patients were asked to fill out an online diary at the end of each day for 2 consecutive weeks. 
They were reminded to do so each evening via a text message. The diary took approximately 5 minutes to 
complete. In this study, only the items which are of relevance for the current research aim are described. 
Items were developed iteratively by a group of pain researchers and piloted for feasibility in patients with 
chronic pain. 
Positive Affect and Negative Affect: Items assessing daily PA and NA were rated on a scale from 
0 (not at all agree) to 6 (totally agree). We used six adjectives for PA and NA respectively: glad [blij], 
enthusiastic [enthousiast], happy [gelukkig], relaxed [ontspannen], strong [sterk] and proud [trots] for PA 
and afraid [bang], irritated [geirriteerd], angry [kwaad], powerless [machteloos], sad [triest] and nervous 
[zenuwachtig] for NA. Items were derived from a validation study investigating the representation of 
emotion terms in a general population [60]. PA and NA scales were calculated by averaging PA and NA 
items respectively. We calculated within-person reliability of the PA and NA scales using the 
Generalizability theory approach described by Bolger and Laurenceau (2013) [7]. Estimates of within-
person reliability were .84 for PA and .77 for NA, indicating that both scales assessed within-person 
changes reliably. Pain severity was assessed using two items: “On average, how severe has your pain been 
today?” and “Which number would you ascribe to the pain you experienced the most today?” both rated 
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on a scale from 0 (no pain) to 10 (worst imaginable pain). As the two pain items were highly correlated 
(within-person correlation was .78, P < .001), we calculated an average score of both items. Pain disability 
was assessed by the item “To what extent did pain interfere with your planned activities?” rated on a scale 
from 0 (not at all) to 10 (very much). This item corresponds to the PDI questioning, but asks more 
generally about the degree to which pain prevents patients from their planned activities. Cognitive 
complaints were assessed by three items: distractibility (“to what extent were you distracted today?”), 
forgetfulness (“to what extent were you forgetful today?”) and clear thinking (“to what extent were you 
able to think clearly today?”) all rated on a scale from 0 (not at all) to 10 (very much). The clear thinking 
item was reverse-coded (subtracting scores from 10) and scores on these three items were averaged to 
form a score for daily cognitive complaints with a range from 0 to 10. The within-person reliability of the 
cognitive complaints scale was .80. These items were selected based on previous research in which 
authors reported frequent cognitive problems of chronic pain patients [34,44].  
 
2.4. Affective instability 
Affective instability, conceptualized as frequent mood shifts over time [26], takes into account the 
size of affective changes as well as their temporal order. It is related to the magnitude of the difference 
from one time-point to another. The mean square of successive differences (MSSD) has been proposed as 
an index of affective instability [26]. It reflects the extent to which consecutively assessed mood states 
differ from each other and, therefore, provides a measure of both variability (i.e., average magnitude of 
affective changes) and temporal dependency (i.e., average frequency of affective changes). In our study, 
this measure reflects both the frequency and size of fluctuations in daily mood over 14 days. The squared 
difference between successive observations at occasions i + 1 and i for a time series of n measurement 
occasions is given by  
 
𝑀𝑆𝑆𝐷 =  
1
𝑁 − 1 
∑(𝑥𝑖+1
𝑁−1
𝑖=1
− 𝑥𝑖)
2 
 
 
This index was calculated separately for PA and NA [see 25,28,55].  
 
2.5. Procedure and data handling  
Diary reports were included in the analyses only if they filled out the diary for at least 10 out of 
the 14 days. The data of four patients were excluded for this reason, providing a final sample of 70 
patients.  
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2.6. Statistical model 
Descriptive statistics and correlation analyses were performed using SPSS statistical software, 
version 19.0 for Windows (SPSS Inc., Chicago/IL). The nested structure of the data (multiple observations 
nested within individuals) requires a multilevel regression approach. The HLM software package (Version 
7.01; Scientific Software International, Skokie/IL) was used [42]. Level 1 variables consisted of the daily 
diary measures of affect (PA and NA), daily pain intensity, pain disability, and cognitive complaints. All 
Level 1 variables were continuous and entered group mean centered [19]. Level 2 variables consisted of 
baseline questionnaire measures of gender, age, pain duration, and baseline disability. Gender was dummy 
coded (0 = female; 1 = male) and entered uncentered, while all continuous Level 2 variables were 
standardized to facilitate interpretation [37]. Full maximum likelihood estimation was used for all models. 
We followed a model building procedure in our analyses [42]. To maximize stability and reliability of the 
findings, we excluded control variables from further steps in model building if their effects proved to be 
non-significant [29]. As suggested by some authors, we controlled for the mean level of daily affect in 
order to get the effect specific to within-individual variability [16,46]. Mean levels of daily PA and NA 
were therefore included in the final analyses at Level 2. The moderating role of affective instability was 
investigated in the last step of model building. Models included random intercepts and random slopes.  
 
3. Results 
3.1. Participant characteristics 
The average age of the patients was 49.7 years (SD = 9.76; range 22-64 years), and 46 were 
female (65.7 %). Most were married (63 %) or living together (10 %). A total of 42.6 % reported a higher 
education level (college or university degree), 55.9 % of the patients had a secondary school degree and 
the remaining 1.5 % had a primary school degree. The sample consisted of a mixed group of chronic pain 
patients. All of them were seeking for help, taking medication, receiving some kind of pain treatment (e.g. 
occupational therapy, chiropractic, manual therapy) and/or seeing a specialist (e.g. orthopedist, 
rheumatologist, oncologist, neurosurgeon, physiotherapist, psychologist). The mean pain duration was 
168.99 months (SD = 111.74) and almost every patient indicated having more than one pain location (M = 
3.81, SD = 1.89; range 1-9). Most frequently reported pain locations were the back (92.9%), neck (67.1%) 
and leg (66.7%).  Mean pain severity was 3.86 as measured by the MPI (SD = 0.97) and mean disability 
was 39.17 on the PDI (SD = 11.34); these mean levels compare well with previously reported data from 
chronic pain patients (MMPI = 4.2, SDMPI = 1.1; MPDI = 44.6, SDPDI = 13.4) [10,38]. On average, the level of 
daily PA was 2.46 (SD = 1.24) and the level of daily NA was 1.75 (SD = 1.12). The mean level of 
instability for PA was 1.08 (SD = 0.98) and for NA 1.06 (SD = 1.01), indicating that, on average, patients’ 
PA and NA levels varied by approximately 1 point (on a scale from 0 to 6) from one day to the next. 
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Those with higher (+1 SD) levels of instability showed differences of approximately 2 scale points in their 
affect levels on successive days, whereas patients’ with lower (-1 SD) levels of instability had near to zero 
differences in their affect levels from day-to-day. Mean scores for state (M = 38, SD = 9.49) and trait 
anxiety (M = 47.17, SD = 11.35) were comparable with those in other chronic pain studies [3,13]. 
Depression scores (M = 8.39, SD = 4.03) were mildly elevated compared to available norms [48].  
 
3.2. Correlation analyses 
Pearson correlations were calculated between NA and PA instability, assessed via end-of-day 
diary, and measures assessed via questionnaires (i.e. depression, state anxiety, trait anxiety, baseline pain 
severity, baseline disability). Further Pearson correlations were calculated between NA and PA instability 
and the mean levels of daily PA and NA, measures based on the daily reported emotions. The two 
measures of affective instability were not related to the mean levels of daily affect. Further, NA instability 
was related to more trait anxiety (STAI), more pain (MPI) and more disability (PDI).  For PA instability 
there were no significant relationships, except with NA instability. An overview of the means and 
correlations is presented in Table 1. 
 
 
- Table 1 about here – 
  
 
3.3. Multilevel analyses 
Separate multilevel models were run with daily disability and daily cognitive complaints as 
outcome measures.  We predicted that NA instability would be positively related to daily disability and 
daily cognitive complaints and moderate the relationship between daily pain severity and its outcomes. 
We derive similar hypotheses to investigate the relationship with PA instability.   
 
3.3.1. NA instability 
Daily disability 
Initial analyses indicated that there was substantial variance in reported daily disability between 
(43 %) and within (57 %) patients. First, we included daily pain severity as a Level 1 predictor. The model 
proved to be better (Χ2 (3) = 367.50, P < .001) than the model without any predictor. Second, we added 
NA instability as a Level 2 predictor, and additional Level 2 measures, i.e. age, gender, pain duration, 
baseline pain severity, pain disability and the mean daily level of NA, as control variables. The proposed 
model proved to be better than the model with only daily pain severity as a Level 1 predictor (Χ2 (7) = 
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44.18, P < .001). Only the mean level of daily NA was a significant predictor for the intercept of daily 
disability (coefficient = .895, t(62) = 5.5, P < .001), indicating that patients reporting more daily NA also 
reported more daily disability. We, therefore, excluded age, gender, pain duration, baseline pain severity 
and pain disability. Third, we included the interaction between NA instability (Level 2) and daily pain 
severity (Level 1) as a cross-level moderator of the Level 1 intercept and slope. The resulting model was 
better than without the cross-level interaction term (Χ2 (3) = .847, P = .037). NA instability was a 
significant predictor for the Level 1 intercept, meaning the mean level of daily disability (coefficient = 
.445, t(67) = 2.27, P = .026), and the Level 1 slope (coefficient = .094, t(67) = 2.09, P = .041), indicating a 
stronger within-person association between daily pain severity and disability for patients who were more 
unstable in their NA. The final model is shown in Table 2. It shows that (1) the mean level of daily NA 
and NA instability are related to daily disability and (2) NA instability moderates the association between 
daily pain severity and daily disability. Some further analyses were performed to test the robustness of our 
findings. For example, when including trait anxiety as a Level 2 variable, there were no significant 
changes for the predictive values of the Level 2 variables. 
 
Daily cognitive complaints 
Initial analyses indicated the presence of substantial variance in reported daily cognitive 
complaints between (60%) and within (40 %) patients. First, we investigated the predicting effect of daily 
pain severity at Level 1. The resulting model proved to be better (Χ2 (3) = 70.13, P < .001) than the model 
without any predictor. Second, we added NA instability as a Level 2 predictor, as were control variables, 
i.e. age, gender, pain duration, baseline pain severity and the mean level of daily NA. This model was 
better than the model with daily pain severity as single Level 1 predictor (Χ2 (6) = 28.06, P < .001). Only 
the mean level of daily NA was a significant predictor for the intercept (coefficient = .77, t (63) = 3.94, P 
< .001), indicating that patients reporting more daily NA also reported a higher level of daily cognitive 
complaints. Age, gender, pain duration and baseline pain severity were excluded from the model as they 
did not show any significant effects. Third, we added the interaction between NA instability (Level 2) and 
daily pain severity (Level 1) as a cross-level moderator of the Level 1 intercept and slope to the model.  
The model proved to be better than without cross-level interaction (Χ2 (2) = 8.73, P = .013). NA instability 
was a significant predictor only for the Level 1 slope (coefficient = .13, t(67) = 2.39, P = .020), indicating 
a stronger within-person association between daily pain severity and cognitive complaints for patients who 
were more unstable in their NA. The final model (Table 2) suggests that (1) the mean level of daily NA is 
related to daily cognitive complaints and (2) NA instability moderates the association between daily pain 
severity and daily cognitive complaints. The robustness of these findings was tested by some further 
analyses. For example, when including trait anxiety as a Level 2 variable, trait anxiety showed to be a 
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significant predictor (coefficient = .63, t (66) = 2.12, P = .038), but not the mean level of daily NA 
(coefficient = .39, t (66) = 1.48, P = .145). There was no change in the moderating role of NA instability.  
 In a series of posthoc-analyses we explored whether the effect of affective instability was 
moderated by age. Age only moderated the effect of NA in the model predicting cognitive complaints. 
Specifically, there was a significant interaction between age and NA instability on the within-person 
association between daily pain and cognitive complaints (coefficient = -.185, t (65) = -2.34, P = .023), 
meaning that the effect of NA instability was larger in younger patients. Age did not moderate the effects 
of affective instability in any of the other three models (Ps > .33). 
 
- Table 2 about here - 
 
3.3.2. PA Instability 
Daily disability 
Initial analyses indicated that there was substantial variance in reported daily disability between 
and within patients, and daily pain severity to be a significant Level 1 predictor (see above). In a next step, 
we added PA instability as a Level 2 predictor and further Level 2 control variables, i.e. age, gender, pain 
duration, baseline pain severity, baseline pain disability and the mean level of daily PA, to our model. The 
proposed model proved to be better than the model with only daily pain severity as Level 1 predictor (Χ2 
(7) = 32.02, P < .001). Only the mean level of daily PA was a significant predictor for the Level 1 
intercept (coefficient = -.69, t (62) = -4.15, P < .001), reflecting the fact that patients reporting more daily 
PA showed less daily disability. Age, gender and pain duration, baseline pain severity and disability were 
dropped from the model, because they were not significant. In a last step, we included the interaction 
between PA instability (Level 2) and daily pain severity (Level 1) as a cross-level moderator of the Level 
1 intercept and slope. Although pointing in the same direction, the model failed to reach significance (Χ2 
(2) = 3.43, P = .178). The final model (Table 3) shows that the mean level of daily PA is related to daily 
disability. Including trait anxiety at Level 2, showed trait anxiety to be a significant predictor (coefficient 
= .46, t (66) = 2.28, P = .026), similar to the mean level of daily PA (coefficient = -.63, t (66) = -2.88, P = 
.005).  
 
Daily cognitive complaints
 
Initial analyses indicated that there was substantial variance in reported daily cognitive complaints 
between and within patients, and daily pain severity to be a significant Level 1 predictor (see above). In a 
next step, we included PA instability as a Level 2 predictor, as were control variables i.e. age, gender, pain 
duration, pain severity at baseline and the mean level of daily PA. The proposed model proved to be better 
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than the model with only daily pain severity as Level 1 predictor (Χ2 (6) = 18.38, P = .006). The mean 
level of daily PA (coefficient = -.48, t (63) = -2.43, P = .018) and baseline pain severity (coefficient = 
.435, t (63) = 2.04, P = .046) were significant predictors for the intercept, indicating that patients reporting 
higher levels of daily PA or lower levels of baseline pain severity reported less cognitive complaints in 
daily life. Due to the non-significant effects of age, gender and pain duration, they were dropped from the 
model. In a last step, we entered the interaction between PA instability (Level 2) and daily pain severity 
(Level 1) as a cross-level moderator of the Level 1 intercept and slope. The resulting model was not better 
than without the cross-level interaction term (Χ2 (2) = .860, P > .500). Results of the final model are 
summarized in Table 3. They reveal that the mean level of daily PA is related to daily cognitive 
complaints. When including trait anxiety as a Level 2 variable, it proved to be a significant predictor 
(coefficient = .78, t (65) = 3.15, P = .002), whereas the significant predictive effect of the mean level of 
daily PA of P = .028 changed to P = .857.  
Additional analyses including depression scores (HADS) showed that despite a positive relation to 
mean levels of daily pain severity, disability and cognitive complaints (correlations ranging from .35 to 
.43), depression did not reliably moderate the within-person associations between daily pain and either 
disability or cognitive complaints (Ps > .18). NA instability remained a significant moderator of the 
associations between daily pain and both disability and cognitive complaints (Ps < .03) even after 
controlling for depressive symptoms. PA instability became a statistically significant moderator of the 
association between daily pain and disability (P =.024).  
 
 
- Table 3 about here - 
 
 
4. Discussion 
This study investigated the role of affective instability in the daily experience of pain, disability 
and cognitive complaints using an end-of-day diary over 14 days. The results can be readily summarized. 
First, the results show a significant relationship between mean levels of daily affect and pain severity and 
disability, confirming previously reported results about the relationship between NA, PA and pain 
[1,41,62]. Second, NA, but not PA, instability predicted daily disability over and above the mean level of 
daily NA, and even after controlling for age, gender, baseline pain severity, pain chronicity and trait 
anxiety. Third, NA instability moderated the relationship between daily pain severity and pain-related 
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outcomes: Daily pain severity was more strongly associated with daily disability and cognitive complaints 
in patients with higher levels of NA instability.  
This study is the first to reveal the role of NA instability in the adjustment to chronic pain. Our 
findings demonstrate that not only the intensity but also the time course and variability of NA is related to 
daily pain outcomes. As this study is the first of its kind, research will need to further corroborate our 
findings, and also investigate underlying processes. One explanation for current findings may be found in 
the type and quality of emotion regulation skills. Indeed, affective instability has previously been 
interpreted as reflecting a dysfunctional regulation of emotions [8,47]. Although this view mostly stems 
from the literature on psychopathology, similar processes may play a role when for chronic pain patients 
have to cope coping with the daily demands of pain [17]. It may well be that individuals who have 
problems with regulating NA also have difficulties to cope with pain and, thus, experience more 
interference by pain in daily life. This interference by pain may result in disability and cognitive 
complaints. If this is true, there may be a strong overlap in regulating pain and regulating NA. This may 
be a reasonable assumption as pain involves a sensory and an emotional experience. Also, Linton argued 
for commonalities in problems of regulation in chronic pain and emotional disorders [30]. An important 
strategy for clinicians may then be to target NA instability. As yet we do not know how this is best 
accomplished. If there are deficits in particular regulation skills, interventions may include skills training, 
such as the Affect Regulation Training [6], which is a module-based intervention to improve emotion 
regulation skills. If, on the other hand, there is evidence for rigid overregulation, mindfulness training 
[21,43] or Acceptance and Commitment Therapy [23,35,61] may be promising approaches.  
A remarkable finding of our study is that NA instability but not PA instability predicted pain-
related outcomes, although the association between NA and PA instability was high. This pattern of 
results is not unusual. Previous research has shown a similar relationship between instability measures of 
PA and NA [28,32]. These findings may be explained by shared method variance between instability 
measures of NA and PA: They are based on similar mathematical algorithms. The finding, however, that 
NA instability, but not PA instability, predicts pain-related outcomes is in line with previous research in 
psychopathology investigating affective instability in natural contexts [25,55,56]. For example, depressed 
patients show higher NA instability, but not PA instability, compared to healthy volunteers [55].  
At first sight, our findings are not in line with the predictions of the dynamic model of affect [14]. 
This model states that NA and PA are relatively independent during non-stressful periods, whereas they 
merge to one bipolar dimension under stressful or painful conditions. From this perspective, one might 
have expected a similar pattern of results for NA and PA instability. Nevertheless, although a relatively 
strong relationship was found between the mean levels of NA and PA instability, only NA instability was 
found to moderate the relationship between pain severity and disability or cognitive complaints. One 
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explanation for not finding such a pattern for PA may relate to the fact that there are fewer fluctuations in 
PA. This is, however, not the case in our study: The level of instability was similar for NA and PA. 
Another explanation may be that our measure of affective instability captures a unique parameter that is 
not addressed by the dynamic model of affect. In line with this argument are the findings that NA 
instability and PA instability are not related to the mean levels of daily NA and PA.  
Our findings corroborate the notion that affective instability does not measure the intensity of 
emotional experiences, but rather their temporal variability. Recently, the examination of the dynamics of 
affect has increased in order to improve our understanding of psychological maladjustment and 
psychopathology [15,25,28,55,56]. Within this emerging field, emotional responding reflects a dynamic 
process that takes place in response to changing contextual demands. Thus, emotional responding that is 
adaptive, is believed to be flexible, rather than rigid or stereotypical [54]. In case of affective instability, 
an individual tends to show frequent mood shifts with a transient, fluctuating course [56]. The distinction 
between intensity and temporal variability completes the picture of dynamically fluctuating emotions in 
daily life and demonstrates the importance of broadening the perspective in order to better understand 
daily emotional experiences. In addition, we found that NA instability, but not PA instability, is related to 
baseline pain severity and baseline disability. This finding expands upon previous research relating 
affective instability to mental disorders [16,55,56] and furthers our understanding of daily functioning, i.e. 
disability and cognitive complaints, of chronic pain patients.  
In consideration of affective instability as a reflection of dysfunctional emotion regulation [8,47], 
we also investigated the relationship between affective instability and measures of emotional functioning, 
i.e. depressive mood and trait anxiety. We only found a negative association between NA instability and 
trait anxiety, which is in line with the model of Hofmann and colleagues (2012), which links dysregulation 
of NA to anxiety disorders [24]. Nevertheless, it is important to note that including trait anxiety in our 
models did not affect the effects of NA instability. Although not the focus of the current study, one might 
further have expected a relationship between depressive mood and affective instability. Hamilton and 
colleagues (2005) suggest that affect regulation may influence psychological functioning in patients with 
chronic pain [22]. They further assume that the reason for the relationship between affect regulation and 
adjustment to pain may be due to the fact that these patients are more vulnerable to depression. In the 
current study, however, we neither found a relationship between affect dysregulation (i.e. affective 
instability) and depression, nor did the inclusion of depressive symptoms in our models change the 
predictive and moderating role of NA instability for daily disability and cognitive complaints. More 
research is needed in this regard. Nevertheless, in line with numerous studies reporting high levels of 
emotional distress in chronic pain patients [4,33,34], we found a strong association between baseline 
depressive mood, anxiety and pain severity. 
14 
This study has some limitations. First, we did not include a control group and therefore we cannot 
compare our findings with a non-clinical sample. Second, we investigated a heterogeneous group of 
chronic pain conditions so that findings cannot be ascribed to specific conditions. Third, the analyses are 
based on end-of-day diaries, assessing fluctuations in affect over days. Our results may be further 
corroborated by also studying within-day emotional fluctuations. Fourth, neither did we have data on 
putative mediating variables such as emotion regulation strategies used, or indicators of failed regulation 
such as perseverative cognitions (i.e. worry and rumination) [18], nor did we include other variables 
known to influence levels of pain-related disability (e.g. pain-related fear) in the analysis. Fifth, the effect 
of affective instability may be moderated by other variables. We found such an effect for age, albeit in 
posthoc-analyses. This finding suggests that emotional experiences may grow more stable with age [9]. 
Sixth, our measure of affective instability captures the temporal fluctuations of emotions over 14 days. 
Nevertheless, it remains unclear which individual or contextual factors may underlie, or be related to, this 
process. Seventh, there is a strong tradition to psychometrically validate questionnaires. The validation of 
diary items is still in its infancy. Although items in the current study were carefully selected and piloted 
for understanding and feasibility in patients with chronic pain, validation of the diary items should be 
further developed (e.g. by using cognitive interviewing [11]). Eighth, our analyses are best considered as 
cross-sectional. We did not perform time lag analyses. Therefore, one should be careful in inferring 
causality between variables. Finally, we only focus upon affective instability as a marker of dysfunctional 
regulation. Other measures are possible, such as psychophysiological measures of emotion regulation 
capacity (i.e. heart rate variability), and their use may further our understanding of their role in the context 
of chronic pain.  
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Table 1 
Means (M), standard deviations (SD) and Pearson correlation coefficients for all measures. 
 M SD 2 3 4 5 6 7 8 9 
1. Instability of PA (MSSD) 1.08 0.98 .683
***
 -.053 .008 .069 .194 .151 .028 -.043 
2. Instability of NA (MSSD) 1.06 1.01  .069 .058 .284
*
 .313
**
 .304
*
 -.120 .088 
3. Depression (HADS-D) 8.4 4.03   .529
***
 .749
***
 .463
***
 .331
**
 -.679
***
 .690
***
 
4. State anxiety (STAI-S) 38 9.49    .609
***
 .184 -.024 -.408
**
 .618
***
 
5. Trait anxiety (STAI-T) 47.17 11.35     .402
**
 .286
*
 -.599
***
 .777
***
 
6. Pain severity (MPI) 3.86 0.97      .554
***
 -.350
**
 .376
**
 
7. Disability (PDI) 39.17 11.34       -.252
*
 .260
*
 
8. Mean daily PA 2.46 1.24        -.585
***
 
9. Mean daily NA 1.75 1.12         
PA, positive affect; NA, negative affect; MSSD, Mean Square Successive Difference; HADS-D, Depression scale of the Hospital Anxiety and 
Depression Scale; STAI-S, State subscale of the State-Trait Anxiety Inventory; STAI-T, Trait subscale of the State-Trait Anxiety Inventory; MPI, 
Multidimensional Pain Inventory; PDI, Pain Disability Index, HADS-D, n = 67. 
     *
 P < .05 
  **
 P < .01 
***
 P < .001 
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Table 2 
Final hierarchical linear models in regard of NA instability. 
Dependent variable 
(diary items) 
 Coefficient SE T 
Daily disability     
 Intercept (β00) 4.484 0.16 27.549*** 
 NA_MSSD (β01) 0.445 0.20 2.272* 
 Mean NA (β02) 1.020 0.17 5.856*** 
 Daily pain severity (β10) 0.916 0.05 18.457*** 
 Daily pain severity  x NA_MSSD (β11) 0.094 0.04 2.085* 
 Daily pain severity x Mean NA (β12) 0.022 0.05 0.411 
Daily cognitive 
complaints 
    
 Intercept (β00) 3.233 0.17 18.635*** 
 NA_MSSD (β01) 0.238 0.16 1.521 
 Mean NA (β02) 0.872 0.16 5.427*** 
 Daily pain severity (β10) 0.277 0.05 5.395*** 
 Daily pain severity x NA_MSSD (β11) 0.128 0.05 2.386* 
 Daily pain severity x Mean NA (β12) 0.070 0.04 1.630 
NA, negative affect; MSSD, Mean Square Successive Difference. 
 
     *
 P < .05 
  **
 P < .01 
***
 P < .001 
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Table 3 
Final hierarchical linear models in regard of PA instability. 
Dependent variable 
(diary items) 
 Coefficient SE T 
Daily disability     
 Intercept (β00) 4.485 0.18 24.963*** 
 PA_MSSD (β01) 0.307 0.16 1.865 
 Mean PA (β02) -0.909 0.19 -4.884*** 
 Daily pain severity (β10) 0.926 0.05 19.056*** 
 Daily pain severity  x PA_MSSD (β11) 0.073 0.05 1.589 
 Daily pain severity x Mean PA (β12) -0.044 0.05 -0.894 
 
Daily cognitive 
complaints 
    
 Intercept (β00) 3.233 0.18 17.919*** 
 Baseline pain severity (β01) 0.531 0.19 2.856** 
 PA_MSSD (β02) -0.094 0.18 -0.525 
 Mean PA (β03) -0.456 0.20 -2.241* 
 Daily pain severity (β10) 0.286 0.06 5.092*** 
 Daily pain severity x PA_MSSD (β11) 0.045 0.04 1.063 
 Daily pain severity x Mean PA (β12) -0.019 0.04 -0.430 
Note. PA, positive affect; MSSD, Mean Square Successive Difference. 
 
     *
 P < .05 
  **
 P < .01 
***
 P < .001 
 
 
